scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Remus Pharmaceuticals Ltd

Feedback
Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Ltd (REMUS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 150
Apr 11, 2025 00:00 IST Closed
  • NSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹2,043.50
₹13.50 (0.67%)
Created with Highcharts 11.1.021:0016:0017:0018:3019:4520252050207521002125
₹2,030.00Low
Today’s Performance
₹2,097.00High
₹1,412.50Low
52 Week’s Performance
₹2,834.75High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day0.67%
  • 1 Week-5.23%
  • 1 Month3.32%
  • 3 Months-2.87%
  • 6 Months-25.00%
  • 1 Year40.75%
  • 3 Years0.00%
  • 5 Years0.00%

PEER COMPARISON

₹2,043.50Remus Pharmaceuticals Ltd
₹1,463.05Cipla Ltd

STOCK SUMMARY

  • Face Value (₹)10.00
  • Beta1.06
  • 52-Week Low (₹)1,412.50
  • 52-Week High (₹)2,834.75
  • Price-to-Book (X)*13.86
  • Dividend Yield (%)0.05
  • Price-to-Earnings (P/E) (X)*55.91
  • Earnings Per Share (₹)36.55
  • Market Cap (₹ Cr.)*1,204.03
  • * Values as of last close price

COMPETITORS

BT TV

Why Banks Reject Loans? Credit Score & CIBIL Explained! 7:24 Why Banks Reject Loans? Credit Score & CIBIL Explained!
Ajay Bagga: Every $10 Drop in Crude Adds 0.1% to India's GDP 1:09 Ajay Bagga: Every $10 Drop in Crude Adds 0.1% to India's GDP
India vs Global Headwinds: Ajay Bagga Picks Sectors That Could Withstand the Storm 1:16 India Vs Global Headwinds: Ajay Bagga Picks Sectors That Could Withstand The Storm
Gold Prices at All-Time Highs: RBI’s Draft Rules Shake Up Gold Loan Stocks 3:22 Gold Prices at All-Time Highs: RBI’s Draft Rules Shake Up Gold Loan Stocks
Italy's Deputy PM Tajani Highlights India as Key Trade Partner Amid Global Trade War 0:59 Italy's Deputy PM Tajani Highlights India As Key Trade Partner Amid Global Trade War
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
No Data For quaterly.
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Created with Highcharts 11.1.029.91​29.91202405101520253035
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 31 Sep 2024)
  • Promoters (70.84%)
  • Domestic institutional investors (0.77%)
  • Foreign Institutional Investors (3.40%)
  • Public & Other(23.49%)
  • Government Holding(0.00%)
  • Corporate Holding(1.51%)
Created with Highcharts 11.1.070.84​70.843.40​3.400.77​0.7723.49​23.490.00​0.001.51​1.51
Created with Highcharts 11.1.070.84​70.8470.66​70.6670.60​70.60Sep 2024Jun 2024Mar 2024020406080

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jul 26, 2023 Sell
CHHATTISGARH INVESTMENTS LIMITED
  • Qty 8000
  • Average Price ₹3,599.03
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Remus Pharmaceuticals Ltd share price previously?
Remus Pharmaceuticals Ltd share price was up by 0.67% from the previous closing price of ₹2,030.00.
Who are peers of Remus Pharmaceuticals Ltd?
The peers of Remus Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Remus Pharmaceuticals Ltd?
The promotor/promotors of Remus Pharmaceuticals Ltd are
What has been 52-week high of Remus Pharmaceuticals Ltd stocks?
The highest price of Remus Pharmaceuticals Ltd stock is ₹2,834.75 in the last 52-week.
What is the share price of Remus Pharmaceuticals Ltd (REMUS) today on NSE?
As on Apr 11, 2025, Remus Pharmaceuticals Ltd (REMUS)’s share price on NSE is Rs 2043.5
What is the market cap of Remus Pharmaceuticals Ltd (REMUS?)
The current market capitalisation of Remus Pharmaceuticals Ltd (REMUS) is 1,204.03 crores
What is Remus Pharmaceuticals Ltd Share symbol?
The symbol of Remus Pharmaceuticals Ltd is REMUS.
What is the PE ratio of Remus Pharmaceuticals Ltd (REMUS)?
The current PE ratio of Remus Pharmaceuticals Ltd (REMUS) is 55.91.
What is the PB ratio of Remus Pharmaceuticals Ltd (REMUS)?
The current PB ratio of Remus Pharmaceuticals Ltd (REMUS) is 13.86.
Today’s High & Low share prices of Remus Pharmaceuticals Ltd (REMUS) on NSE?
Today, the share price of Remus Pharmaceuticals Ltd (REMUS) on NSE touched a high of Rs 2097 and a low of Rs 2030
What price did Remus Pharmaceuticals Ltd (REMUS) shares open on the NSE today?
On NSE, the share price of Remus Pharmaceuticals Ltd (REMUS) opened at Rs 2097
What is the 52-week high of Remus Pharmaceuticals Ltd (REMUS)?
The 52-week high price of Remus Pharmaceuticals Ltd (REMUS) is Rs 2834.75
What is the 52-week low of Remus Pharmaceuticals Ltd (REMUS) ?
The 52-week low price of Remus Pharmaceuticals Ltd (REMUS) is Rs 1412.5

ABOUT REMUS PHARMA.

Remus Pharmaceuticals Ltd, incorporated in the year 2015, has its registered office in 1101 to 1103 South Tower One42, B/H Ashok Vatika Amblibopal Rd, Ahmedabad, Gujarat, 380054, 91-079-29999857. The main industry in which Remus Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Remus Pharmaceuticals Ltd is/are Parikh & Majmudar/Pankaj R Shah & Associates. In the main management, is chairman and is the company secretary for Remus Pharmaceuticals Ltd.

  • No Data For About.

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.
Advertisement